These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 38635435)

  • 1. Whether Whole Eye Transplant is a Benefit or Harm Depends on More Than the Observer.
    Baugh M; Sabatello M
    Am J Bioeth; 2024 May; 24(5):87-90. PubMed ID: 38635435
    [No Abstract]   [Full Text] [Related]  

  • 2. Do observer and self-reports of ictal eye closure predict psychogenic nonepileptic seizures?
    Syed TU; Arozullah AM; Suciu GP; Toub J; Kim H; Dougherty ML; Wehner T; Stojic A; Syed I; Alexopoulos AV
    Epilepsia; 2008 May; 49(5):898-904. PubMed ID: 18070093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A framework for organizing and selecting quantitative approaches for benefit-harm assessment.
    Puhan MA; Singh S; Weiss CO; Varadhan R; Boyd CM
    BMC Med Res Methodol; 2012 Nov; 12():173. PubMed ID: 23163976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inter-observer agreement of baseline whole body MRI in multiple myeloma.
    Croft J; Riddell A; Koh DM; Downey K; Blackledge M; Usher M; Boyd K; Kaiser M; Messiou C
    Cancer Imaging; 2020 Jul; 20(1):48. PubMed ID: 32665028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A computational observer model of spatial contrast sensitivity: Effects of photocurrent encoding, fixational eye movements, and inference engine.
    Cottaris NP; Wandell BA; Rieke F; Brainard DH
    J Vis; 2020 Jul; 20(7):17. PubMed ID: 32692826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eligibility for the kidney transplant wait list: a model for conceptualizing patient risk.
    Kiberd BA; Tennankore KK; West K
    Transplant Res; 2014 Jan; 3(1):2. PubMed ID: 24401550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Harm and benefits of primary liver resection and salvage transplantation for hepatocellular carcinoma.
    Cucchetti A; Vitale A; Del Gaudio M; Ravaioli M; Ercolani G; Cescon M; Zanello M; Morelli MC; Cillo U; Grazi GL; Pinna AD
    Am J Transplant; 2010 Mar; 10(3):619-27. PubMed ID: 20121741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using a patient-centered approach to benefit-harm assessment in treatment decision-making: a case study in uveitis.
    Yu T; Holbrook JT; Thorne JE; Puhan MA
    Pharmacoepidemiol Drug Saf; 2016 Apr; 25(4):363-71. PubMed ID: 26798977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determining the harm-benefit balance of an intervention: for each patient.
    Prescrire Int; 2014 Nov; 23(154):274-7. PubMed ID: 25954801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global variation of risk thresholds for initiating statins for primary prevention of cardiovascular disease: a benefit-harm balance modelling study.
    Yebyo HG; Zappacosta S; Aschmann HE; Haile SR; Puhan MA
    BMC Cardiovasc Disord; 2020 Sep; 20(1):418. PubMed ID: 32942999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interventions during pregnancy to prevent preterm birth: an overview of Cochrane systematic reviews.
    Medley N; Vogel JP; Care A; Alfirevic Z
    Cochrane Database Syst Rev; 2018 Nov; 11(11):CD012505. PubMed ID: 30480756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of head turn and illumination on the perceived direction of gaze.
    West RW
    Perception; 2013; 42(5):495-507. PubMed ID: 23964376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness, benefit harm and cost effectiveness of colorectal cancer screening in Austria.
    Jahn B; Sroczynski G; Bundo M; Mühlberger N; Puntscher S; Todorovic J; Rochau U; Oberaigner W; Koffijberg H; Fischer T; Schiller-Fruehwirth I; Öfner D; Renner F; Jonas M; Hackl M; Ferlitsch M; Siebert U;
    BMC Gastroenterol; 2019 Dec; 19(1):209. PubMed ID: 31805871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benefit-harm analysis and charts for individualized and preference-sensitive prevention: example of low dose aspirin for primary prevention of cardiovascular disease and cancer.
    Puhan MA; Yu T; Stegeman I; Varadhan R; Singh S; Boyd CM
    BMC Med; 2015 Oct; 13():250. PubMed ID: 26423305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Man versus machine: comparison of naked-eye estimation and quantified capillary refill.
    Toll John R; Henricson J; Anderson CD; Björk Wilhelms D
    Emerg Med J; 2019 Aug; 36(8):465-471. PubMed ID: 31308133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Informing Patient-Centered Care Through Stakeholder Engagement and Highly Stratified Quantitative Benefit-Harm Assessments.
    Aschmann HE; Boyd CM; Robbins CW; Chan WV; Mularski RA; Bennett WL; Sheehan OC; Wilson RF; Bayliss EA; Leff B; Armacost K; Glover C; Maslow K; Mintz S; Puhan MA
    Value Health; 2020 May; 23(5):616-624. PubMed ID: 32389227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Ophthalmologist and Large Language Model Chatbot Responses to Online Patient Eye Care Questions.
    Bernstein IA; Zhang YV; Govil D; Majid I; Chang RT; Sun Y; Shue A; Chou JC; Schehlein E; Christopher KL; Groth SL; Ludwig C; Wang SY
    JAMA Netw Open; 2023 Aug; 6(8):e2330320. PubMed ID: 37606922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The value of blood oxygenation level-dependent (BOLD) MR imaging in differentiation of renal solid mass and grading of renal cell carcinoma (RCC): analysis based on the largest cross-sectional area versus the entire whole tumour.
    Wu GY; Suo ST; Lu Q; Zhang J; Zhu WQ; Xu JR
    PLoS One; 2015; 10(4):e0123431. PubMed ID: 25875306
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.